Truist analyst Bill Chappell raised the firm’s price target on Procter & Gamble to $180 from $175 and keeps a Buy rating on the shares following quarterly results. The firm is also lowering its FY25 sales to $85.785B from $85.932B, prior, and raising its FY26 sales to $88.967B from $88.578B, prior. Additionally, Truist is raising its FY25 and FY26 Core EPS estimates to $6.95 and $7.42 from $6.87 and $7.26, prior.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target raised to $191 from $174 at Morgan Stanley
- Procter & Gamble price target raised to $183 from $180 at Evercore ISI
- Netflix reports Q3 beat, CVS CEO Lynch steps down: Morning Buzz
- Procter & Gamble Highlights Market Trends and Regulations
- PG Earnings: Procter & Gamble Beats Earnings but Misses Sales Estimates in Q1